Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada

Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-06-02

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data